|
FDA
approves Intralytix’s Food Safety Product (LMP 102)
Baltimore, MD, August 19, 2006: Intralytix,
Inc. announced today that the Food and Drug Administration has approved LMP
102 for use on ready-to-eat food. LMP 102 is a bacteriophages based food
safety product effective against Listeria monocytogenes. LMP 102 is
the first and only bacteriophage-based product approved by FDA. Listeria
monocytogenes is the deadliest foodborne pathogen found in ready to eat
foods. “We are pleased with the approval by FDA of LMP 102. It is our
intent to seek approval for additional food safety products effective
against E. coli O157:H7 and Salmonella in the next 12 months”
said John Vazzana, President and CEO of Intralytix.
Intralytix (www.intralytix.com)
is a biotechnology company focused on the development of bacteriophage-based
products for the food safety, animal health and human health markets.
Intralytix is one of the world’s leading companies in phage technology. Its
offices and laboratories are located in Baltimore, Maryland.
For more information,
contact John Vazzana, President & CEO, 540-592-3501 or jvazzana@intralytix.com.
|
